Replies to post #206 on Vanda Pharmaceuticals, Inc. (VNDA)

[surf1944]

7:10AM Vanda Pharma reports EPS in-line, misses on revs (VNDA) 7.86 : Reports Q1 (Mar) net of breakeven, in-line with the Thomson Reuters consensus of ($0.00); revenues fell 39.5% year/year to $7.5 mln vs the $8.1 mln consensus.